Insider · CIK 0001608536

Coiante Scott M

Reports to the SEC for 3 companies · SPRING, TX

sec.gov

Transactions

Companies

Filings

CIK

0001608536

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	−160K sh	—	—	320,473
2026-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	SVP, Chief Financial Officer	MExercise/Conversion	+160K sh	—	—	160,237
2026-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	SVP, Chief Financial Officer	FTax Payment	−54.9K sh	$1.47	−$80.7K	105,356
2026-02-12	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	SVP, Chief Financial Officer	AAward	+273K sh	—	—	272,680
2026-02-12	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	SVP, Chief Financial Officer	AAward	+409K sh	—	—	409,020
2025-02-13	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	SVP, Chief Financial Officer	AAward	+721K sh	—	—	721,070
2025-02-13	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	SVP, Chief Financial Officer	AAward	+481K sh	—	—	480,710
2025-01-02	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	SVP, Chief Financial Officer	AAward	+230K sh	—	—	230,000
2024-08-26	AGILE THERAPEUTICS INCD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−15K sh	$1.52	−$22.8K	5,080
2024-08-26	AGILE THERAPEUTICS INCD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−5,080 sh	$1.52	−$7,721.6	0
2023-10-03	AGILE THERAPEUTICS INCA Award	Chief Financial Officer	AAward	+20K sh	—	—	20,080
2022-07-28	APREAprea Therapeutics, Inc. · Stock Option (right to Buy)A Award	SVP, Chief Financial Officer	AAward	+89.2K sh	—	—	89,200
2022-07-28	APREAprea Therapeutics, Inc.A Award	SVP, Chief Financial Officer	AAward	+60.8K sh	—	—	145,065
2022-06-03	APREAprea Therapeutics, Inc.F Tax Payment	SVP, Chief Financial Officer	FTax Payment	−35.3K sh	$0.81	−$28.4K	84,265
2022-03-10	APREAprea Therapeutics, Inc. · Stock Option (right to Buy)A Award	SVP, Chief Financial Officer	AAward	+186K sh	—	—	185,900
2022-03-10	APREAprea Therapeutics, Inc.A Award	SVP, Chief Financial Officer	AAward	+42.9K sh	—	—	119,549
2022-02-25	APREAprea Therapeutics, Inc.F Tax Payment	SVP, Chief Financial Officer	FTax Payment	−14.8K sh	$1.74	−$25.8K	76,649
2021-08-25	APREAprea Therapeutics, Inc.F Tax Payment	SVP, Chief Financial Officer	FTax Payment	−7,534 sh	$3.98	−$30K	91,466
2021-02-25	APREAprea Therapeutics, Inc.A Award	SVP, Chief Financial Officer	AAward	+33K sh	—	—	35,500
2021-02-25	APREAprea Therapeutics, Inc.A Award	SVP, Chief Financial Officer	AAward	+63.5K sh	—	—	99,000
2021-02-25	APREAprea Therapeutics, Inc. · Stock Option (right to Buy)A Award	SVP, Chief Financial Officer	AAward	+143K sh	—	—	143,000
2020-03-24	APREAprea Therapeutics, Inc. · Stock Option (right to Buy)A Award	SVP, Chief Financial Officer	AAward	+55K sh	—	—	55,000
2019-10-07	APREAprea Therapeutics, Inc. · Stock Option (right to Buy)A Award	SVP, Chief Financial Officer	AAward	+151K sh	—	—	150,824
2019-10-07	APREAprea Therapeutics, Inc.P Purchase	SVP, Chief Financial Officer	PPurchase	+2,500 sh	$15.00	+$37.5K	2,500
2019-01-29	AGILE THERAPEUTICS INCEmployee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+38.5K sh	—	—	38,500
2019-01-29	AGILE THERAPEUTICS INCEmployee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+173K sh	—	—	172,600
2019-01-25	AGILE THERAPEUTICS INCM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+17.5K sh	—	—	48,256
2019-01-25	AGILE THERAPEUTICS INCRestricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−17.5K sh	—	—	0
2019-01-24	AGILE THERAPEUTICS INCRestricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−16.1K sh	—	—	17,500
2019-01-24	AGILE THERAPEUTICS INCM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+16.1K sh	—	—	30,756
2018-06-20	AGILE THERAPEUTICS INCEmployee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+150K sh	—	—	150,000
2018-01-25	AGILE THERAPEUTICS INCM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+17.5K sh	—	—	21,439
2018-01-25	AGILE THERAPEUTICS INCF Tax Payment	Chief Financial Officer	FTax Payment	−6,753 sh	$3.32	−$22.4K	14,686
2018-01-25	AGILE THERAPEUTICS INCRestricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+17.5K sh	—	—	33,570
2018-01-24	AGILE THERAPEUTICS INCEmployee Stock Options (Right to Buy)A Award	Chief Financial Officer	AAward	+107K sh	—	—	107,000
2018-01-24	AGILE THERAPEUTICS INCRestricted Stock UnitsA Award	Chief Financial Officer	AAward	+16.1K sh	—	—	51,070
2017-01-25	AGILE THERAPEUTICS INCEmployee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2017-01-25	AGILE THERAPEUTICS INCRestricted Stock UnitsA Award	Chief Financial Officer	AAward	+35K sh	—	—	35,000
2016-02-08	AGILE THERAPEUTICS INCEmployee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+95K sh	—	—	95,000
2015-02-19	AGILE THERAPEUTICS INCEmployee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+37.5K sh	—	—	37,500
2015-02-19	AGILE THERAPEUTICS INCEmployee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+37.5K sh	—	—	37,500

Recent filings

Accepted (ET)
Mar 34
Coiante Scott M0001062822-26-000035
SEC(opens sec.gov)
Feb 174
Coiante Scott M0001062822-26-000020
SEC(opens sec.gov)
Feb 184
Coiante Scott M0001127602-25-005212
SEC(opens sec.gov)
Jan 24
Coiante Scott M0001127602-25-000084
SEC(opens sec.gov)
Aug 264
Coiante Scott M0001104659-24-092946
SEC(opens sec.gov)
Oct 44
Coiante Scott M0001104659-23-106855
SEC(opens sec.gov)
Aug 14
Coiante Scott M0001104659-22-084760
SEC(opens sec.gov)
Jun 74
Coiante Scott M0001104659-22-069009
SEC(opens sec.gov)
Mar 144
Coiante Scott M0001104659-22-033391
SEC(opens sec.gov)
Mar 14
Coiante Scott M0001104659-22-028760
SEC(opens sec.gov)
Aug 274
Coiante Scott M0001104659-21-110596
SEC(opens sec.gov)
Mar 14
Coiante Scott M0001140361-21-006728
SEC(opens sec.gov)

Companies

Address

2445 TECHNOLOGY FOREST BLVD 11TH FLOOR

SPRING, TX, 77381